GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment
Nuermberger, Eric, Maria Santos Martínez, Sanz, Olalla, Urones, Beatriz, Esquivias, Jorge, Soni, Heena, Tasneen, Rokeya, Tyagi, Sandeep, Si-Yang, Li, Converse, Paul J, Boshoff, Helena I, Robertson, Gregory Thomas, Besra, Gurdyl, Abrahams, Katherine A, Upton, Anna, Mdluli, Khisimuzi, Boyle, Gary W, Turner, Sam, Fotouhi, Nader, Cammack, Nicholas C, Juan Miguel Siles, Alonso, Marta, Excribano, Jaime, Lelièvre, Joël, Perez-Herran, Esther Maria, Bates, Robert H, Maher-Edwards, Gareth X, Barros-Aguirre, David, Ballell, Lluís, Jimenez, Elena N
Published in bioRxiv (06.02.2022)
Published in bioRxiv (06.02.2022)
Get full text
Paper